The Use of Mesalamine Suppositories in Patients with Mild to Moderate Ulcerative Proctitis

Dr. Mark Lamet, from the Center for Gastrointestinal Disorders in Hollywood, Florida, discusses the symptoms, epidemiology, and management of ulcerative proctitis. He focuses on the treatment options for this condition, paying particular attention to the use of topical 5-aminosalicylic acid (5-ASA) as first-line therapy, the extent of therapeutic efficacy with the use of suppositories, and a comparison of a new strength of mesalamine suppositories (1 g h.s.) with standard dosing.


Approx. 11 minutes
23 slides

Date: 2004/07
Location: Montreal, Quebec

   
   
 
For details on how to download and install this presentation, click here.
Return to Main